EZH2 and neoplasm: Under chemotherapy induction, EZH2-mediated H3K27me3 deposition in the SLFN11 gene body suppresses SLFN11 expression, thereby enhancing DNA repair efficiency, enabling tumor cell adaptation and survival (90).